Current filters:  
United States
Manatt, Phelps & Phillips LLP
This study uses publicly available data to examine the financial structure and performance of acute hospitals and health systems in Rhode Island (RI) and compare trends with Connecticut (CT) and Massachusetts (MA).
Davis Wright Tremaine
Aetna recently announced that it is rolling out a national protocol under which it will be reviewing both physician and hospital emergency department claims that include Level 4 or 5 evaluation ...
Ankura Consulting Group LLC
In the latest episode of the Ankura podcast, Michelle Mader, Ankura Healthcare Strategy expert, and Ray Anderson, Chief Strategy Officer of Trinity Health offer their insight...
Arnold & Porter
Life Sciences & Healthcare Regulatory practice co-chair Mahnu Davar was quoted in the Bloomberg Law article, "FDA Lab Test Authority Set for Compliance Hurdles, Legal Fights." The article discusses the U.S. Food...
Oblon, McClelland, Maier & Neustadt, L.L.P
Clinical trials are a critical part of the development and approval process for drugs, biologics, and medical devices. The lengthy and public nature of clinical trials, however, can create challenges...
Arnold & Porter
In our blog post on 22 February 2024 we reported on the Medicines and Healthcare products Regulatory Agency (MHRA) announcement that it intended to launch a regulatory sandbox for software and AI medical devices called the "AI-Airlock".
Arnold & Porter
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published its strategic approach to artificial intelligence (AI).
Crowell & Moring LLP
Talc is a mineral ingredient used in many cosmetic and personal care products, including baby powder, root touch-up products, and blush.
Manatt, Phelps & Phillips LLP
On May 8, the House Committee on Ways and Means (W&M) held a markup to consider six health-related bills. All of the bills were reported favorably out of the committee.
Arnold & Porter
On May 6, 2024, the FDA published its highly anticipated final rule, which was formally published in the Federal Register on May 6, revising the regulatory definition of an IVD product to explicitly capture IVDs manufactured by laboratories.
On April 18, 2024, the U.S. Department of Health and Human Services (HHS) Health Resources and Services Administration (HRSA) released a new Final Rule for its oft-criticized 340B Administrative Dispute Resolution (ADR) Program (2024 Final Rule).
Holland & Knight
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
Foley & Lardner
Given data integrity issues that have been uncovered in the past, in April 2024, the U.S. Food and Drug Administration (FDA) published a draft guidance to applicants and testing site...
Venable LLP
Employer group health plans must make an annual disclosure of the plan's prescription drug and healthcare spending to the Centers for Medicare & Medicaid Services (CMS).
Bass, Berry & Sims
Asembia's 20th Annual Specialty Pharmacy Summit once again brought investors and operators in the specialty pharmacy ecosystem to Las Vegas for learning sessions and networking.
On May 8, 2024, the U.S. House of Representatives Ways & Means Committee passed a bipartisan bill entitled the "Preserving Telehealth, Hospital and Ambulance Access Act"...
Dickinson Wright PLLC
Dickinson Wright attorney Kim Ruppel recently participated in The Risky Health Care Business Podcast...
Alvarez & Marsal
A vision to nurture and scale a new category in the care delivery ecosystem and create a health information fiduciary is the innovative Moonshot of our most recent...
Wiley Rein
Over the last two months, there has been a steady influx of regulatory and legislative efforts regarding drug pricing and the pharmacy industry.
Ankura Consulting Group LLC
Ankura is pleased to present an overview of healthcare transactions announced or closed during Q1 2024 in the United States.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Mondaq Social Media